EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Matrix metalloproteinase activation and TNF upregulation characterize the sclerotic phase of aortic valve disease

Elizabeth Chan-Delgado, Claudia Lerma, Juan C Echeverría, Andrea Toledo, José M Torres-Arellano, Oscar Infante, Rafael Bojalil, Jorge E Cossío-Aranda, Nydia Ávila-Vanzzini, Luis M Amezcua-Guerra, Rashidi Springall

British Journal of Biomedical Science · 13.05.2026 · 83

DOI: 10.3389/bjbs.2026.16540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Biomedical Science, online erschienen am 13.05.2026. Verfasst von Elizabeth Chan-Delgado und 10 weiteren Autor:innen. Beteiligte Einrichtung: Master's Program in Chemical-Biological Sciences, National School of Biological Sciences, National Polytechnic Institute, Mexico City, Mexico. Hauptthemen laut MEDLINE: Tumor Necrosis Factor-alpha, Aortic Valve, Aortic Valve Stenosis, Matrix Metalloproteinases. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Aortic valve sclerosis (AVSc) is an active pathological process driven by extracellular matrix remodeling, consistent with a potentially reversible early stage of aortic valve disease.

Methods

In this cross-sectional study of 168 participants (29, normal aortic valve [NAV]; 98, AVSc; 41, aortic stenosis [AS]), serum levels of matrix metalloproteinase (MMP)-1, -2, -3, and -9, tissue inhibitor of metalloproteinases-1 (TIMP-1), tumor necrosis factor (TNF), interleukin-6 (IL-6), and transforming growth factor-beta (TGF-β) were measured. Multivariable adjustments were performed.

Results

Compared with AS, AVSc was associated with higher circulating MMP-9 levels, with MMP-9 also increased relative to NAV. TIMP-1 concentrations were reduced in AVSc compared with both AS and NAV. TNF levels were higher in AVSc than in AS, while IL-6 and TGF-β did not differ among groups. Notably, MMP-9/TIMP-1 ratio was markedly increased in AVSc.

Discussion

Our findings suggest that AVSc may exhibit an active proteolytic and inflammatory profile amenable to targeted anti-inflammatory and anti-proteolytic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Necrosis Factor-alphaAortic ValveAortic Valve StenosisMatrix MetalloproteinasesAortic Valve DiseaseHumansFemaleMaleTissue Inhibitor of Metalloproteinase-1SclerosisMatrix Metalloproteinase 9Cross-Sectional StudiesMiddle AgedInterleukin-6AgedUp-RegulationTransforming Growth Factor beta

Stichwörter der Autor:innen

aortic valve sclerosisaortic valve stenosisextracellular matrixmetalloproteinasestumor necrosis factor

Substanzen

Tumor Necrosis Factor-alphaTissue Inhibitor of Metalloproteinase-1Matrix Metalloproteinase 9TIMP1 protein, humanInterleukin-6Transforming Growth Factor betaMatrix MetalloproteinasesTNF protein, human

Autor:innen und Institutionen

  • Master's Program in Chemical-Biological Sciences, National School of Biological Sciences, National Polytechnic Institute, Mexico City, Mexico.
  • Department of Immunology, National Institute of Cardiology Ignacio Chávez, Mexico City, Mexico.
  • Red MEDICI, Faculty of Higher Studies Iztacala, National Autonomous University of Mexico, Mexico City, Mexico.
  • Department of Molecular Biology, National Institute of Cardiology Ignacio Chávez, Mexico City, Mexico.
  • Department of Electrical Engineering, Metropolitan Autonomous University-Iztapalapa, Mexico City, Mexico.
  • Department of Electromechanical Instrumentation, National Institute of Cardiology Ignacio Chávez, Mexico City, Mexico.

Zitieren

APA

Chan-Delgado, E., Lerma, C., Echeverría, J. C., Toledo, A., Torres-Arellano, J. M., Infante, O., Bojalil, R., Cossío-Aranda, J. E., Ávila-Vanzzini, N., Amezcua-Guerra, L. M., & Springall, R. (2026). Matrix metalloproteinase activation and TNF upregulation characterize the sclerotic phase of aortic valve disease. British Journal of Biomedical Science, 83. https://doi.org/10.3389/bjbs.2026.16540

Vancouver

Chan-Delgado E, Lerma C, Echeverría JC, Toledo A, Torres-Arellano JM, Infante O, et al. Matrix metalloproteinase activation and TNF upregulation characterize the sclerotic phase of aortic valve disease. British Journal of Biomedical Science. 2026;83. doi:10.3389/bjbs.2026.16540

BibTeX
@article{ChanDelgado2026,
  author = {Chan-Delgado, Elizabeth and Lerma, Claudia and Echeverría, Juan C and Toledo, Andrea and Torres-Arellano, José M and Infante, Oscar and Bojalil, Rafael and Cossío-Aranda, Jorge E and Ávila-Vanzzini, Nydia and Amezcua-Guerra, Luis M and Springall, Rashidi},
  title = {Matrix metalloproteinase activation and TNF upregulation characterize the sclerotic phase of aortic valve disease},
  journal = {British Journal of Biomedical Science},
  year = {2026},
  volume = {83},
  doi = {10.3389/bjbs.2026.16540}
}
Kostenlos starten →